Group One Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-9,478
| Closed | -$36K | – | 6472 |
|
|
2020
Q1 | $36K | Sell |
9,478
-30,008
| -76% | -$129K | ﹤0.01% | 3932 |
|
|
2019
Q4 | $201K | Buy |
39,486
+16,701
| +73% | +$88.3K | ﹤0.01% | 3169 |
|
|
2019
Q3 | $115K | Buy |
+22,785
| New | +$114K | ﹤0.01% | 3470 |
|
|
2019
Q1 | – | Sell |
-70,779
| Closed | -$320K | – | 5661 |
|
|
2018
Q4 | $297K | Sell |
70,779
-5,650
| -7% | -$28.8K | ﹤0.01% | 2376 |
|
|
2018
Q3 | $479K | Buy |
76,429
+12,863
| +20% | +$98.8K | ﹤0.01% | 2329 |
|
|
2018
Q2 | $511K | Buy |
63,566
+41,800
| +192% | +$319K | ﹤0.01% | 2270 |
|
|
2018
Q1 | $162K | Sell |
21,766
-45,444
| -68% | -$302K | ﹤0.01% | 2929 |
|
|
2017
Q4 | $400K | Buy |
67,210
+23,220
| +53% | +$141K | ﹤0.01% | 2438 |
|
|
2017
Q3 | $324K | Buy |
43,990
+25,362
| +136% | +$161K | ﹤0.01% | 2399 |
|
|
2017
Q2 | $126K | Buy |
+18,628
| New | +$138K | ﹤0.01% | 2970 |
|
|
2017
Q1 | – | Sell |
-12,390
| Closed | -$124K | – | 5198 |
|
|
2016
Q4 | $107K | Sell |
12,390
-5,876
| -32% | -$43.4K | ﹤0.01% | 2808 |
|
|
2016
Q3 | $116K | Buy |
+18,266
| New | +$110K | ﹤0.01% | 2845 |
|
|
2016
Q2 | – | Sell |
-33,796
| Closed | -$163K | – | 5104 |
|
|
2016
Q1 | $147K | Buy |
33,796
+19,325
| +134% | +$86.1K | ﹤0.01% | 2539 |
|
|
2015
Q4 | $89K | Buy |
14,471
+10,900
| +305% | +$71.5K | ﹤0.01% | 3056 |
|
|
2015
Q3 | $20K | Sell |
3,571
-34,080
| -91% | -$262K | ﹤0.01% | 4050 |
|
|
2015
Q2 | $281K | Buy |
37,651
+18,347
| +95% | +$111K | ﹤0.01% | 2280 |
|
|
2015
Q1 | $115K | Buy |
+19,304
| New | +$121K | ﹤0.01% | 2813 |
|
|
2014
Q1 | – | Sell |
-41,603
| Closed | -$213K | – | 5751 |
|
|
2013
Q4 | $222K | Sell |
41,603
-847
| -2% | -$3.73K | ﹤0.01% | 2342 |
|
|
2013
Q3 | $214K | Buy |
42,450
+28,866
| +213% | +$157K | ﹤0.01% | 2325 |
|
|
2013
Q2 | $61K | Buy |
+13,584
| New | +$61K | ﹤0.01% | 3257 |
|
Other funds holding PGNX
Group One Trading's PGNX Position: Q2 2020 in Review
Group One Trading sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 9,478 shares — an estimated $36K sold.
Group One Trading first reported a position in PGNX in Q2 2013 and held it in 20 quarters. The position peaked at $511K in Q2 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.
- Group One Trading reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
- Group One Trading sold 9,478 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $36K.
- Group One Trading first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
- Group One Trading's Progenics Pharmaceuticals Inc position peaked at $511K in Q2 2018.
- 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.
Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.